Investigating early-onset osteoporosis in individuals with Down syndrome (#216)
Michelle Maugham-Macan
1
,
Bridgette O'Malley
1
,
Georgia Kafer
1
- University of the Sunshine Coast, Sippy Downs, QLD, Australia
Publish consent withheld
- 1. de Graaf, G., F. et al., Genet Med, 2017. 19(4): p. 439-447.
- 2. Down Syndrome Statistics in Australia. 2011 19 June 2023.
- 3. Sherman, K.M., et al., Low bone mass and impaired fracture healing in mouse models of Trisomy21 (Down syndrome). Bone, 2022. 162: p. 116471.
- 4. Lee, Y., et al., Negative Feedback Inhibition of NFATc1 by DYRK1A Regulates Bone Homeostasis. Journal of Biological Chemistry, 2009. 284(48): p. 33343-33351.
- 5. LaCombe, J.M. and R.J. Roper, Skeletal dynamics of Down syndrome: A developing perspective. Bone, 2020. 133: p. 115215.
- 6. Fowler, T.W., et al., Low Bone Turnover and Low BMD in Down Syndrome: Effect of Intermittent PTH Treatment. PLOS ONE, 2012. 7(8): p. e42967.
- 7. González-Agüero, A., et al., Bone mass in male and female children and adolescents with Down syndrome. Osteoporosis International, 2011. 22(7): p. 2151-2157.
- 8. Garcia-Ramírez, M., et al., Down's Syndrome: Altered Chondrogenesis in Fetal Rib. Pediatric Research, 1998. 44(1): p. 93-98.
- 9. Kjaer, M.S., et al., Hand development in trisomy 21. Am J Med Genet, 1998. 79(5): p. 337-42.